Related Experiment Videos
Alteration of cell cycle-related genes in hepatocarcinogenesis
N Nishida1, Y Fukuda, K Ishizaki
1Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Japan.
Abstract:
The mammalian cell cycle is controlled by regulators of the G1 to S transition such as tumor suppressor proteins, p53 and retinoblastoma (RB); cyclin D1 and cyclin-dependent kinase 4; and inhibitor of cyclin dependent kinase, p16INK4A. Recently, aberrations of these cell cycle-related genes have been reported to contribute to the formation and development of cancer. In human hepatocellular carcinoma (HCC), high frequencies of aberration have been detected in the p53 and RB genes. Loss of heterozygosity (LOH) of chromosome 13q was detected in 35% of HCC and LOH on chromosome 17p was detected in 49%. Mutation of the p53 gene was also detected in 32%. The aberrations of these genes were observed more frequently in poorly differentiated and in advanced HCCs. On the other hand, genetic alterations of the cyclin D1 and p16INK4A genes were not so frequent, but appeared to be associated with the aggressive behavior of the tumor, which suggests that disruption of the cell cycle-related genes results in the progression of HCC. Further study with a substantial number of cases is required to determine the actual frequency of the aberrations of the G1 controlling genes in hepatocarcinogenesis.
Insights
Cell cycle regulators like p53 and retinoblastoma (RB) gene aberrations are frequent in hepatocellular carcinoma (HCC), especially in advanced stages. These genetic changes in HCC progression highlight the role of cell cycle disruption in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The mammalian cell cycle, particularly the G1 to S transition, is regulated by key proteins including p53, retinoblastoma (RB), cyclin D1, CDK4, and p16INK4A.
- Aberrations in these cell cycle regulators are increasingly linked to cancer formation and progression.
Purpose of the Study:
- To investigate the frequency and significance of cell cycle gene aberrations in human hepatocellular carcinoma (HCC).
- To correlate genetic alterations with tumor differentiation and stage in HCC patients.
Main Methods:
- Analysis of genetic alterations, including mutations and loss of heterozygosity (LOH), in cell cycle-related genes (p53, RB, cyclin D1, p16INK4A).
- Correlation of observed genetic aberrations with clinicopathological features of HCC, such as differentiation and tumor stage.
Main Results:
- High frequencies of aberrations were found in p53 (32% mutation) and RB genes.
- Loss of heterozygosity (LOH) was detected in 35% of chromosome 13q and 49% of chromosome 17p.
- Aberrations in p53 and RB were more common in poorly differentiated and advanced HCCs.
- While less frequent, alterations in cyclin D1 and p16INK4A were associated with aggressive tumor behavior.
Conclusions:
- Disruption of cell cycle regulatory genes, particularly p53 and RB, plays a significant role in the progression of HCC.
- Further research with larger cohorts is needed to fully elucidate the role of G1 controlling genes in hepatocarcinogenesis.